SHELLY VLIET: Open Payments
NPI 1992292353 · WILLIAMSTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 50 payments from 15 companies in 2025. Trend: 2023 $1,173 · 2024 $1,522 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $161 |
| Novo Nordisk Inc | 6 | $140 |
| PFIZER INC. | 5 | $86 |
| Lilly USA, LLC | 4 | $74 |
| Amgen Inc. | 4 | $68 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Astellas Pharma US Inc | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $18 |
Products named: Ozempic, VRAYLAR, MOUNJARO, QULIPTA, EVENITY, PREVNAR 20, Rybelsus, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
